Safety and Efficacy of 50 mg NYX-783 QD vs. Placebo in PTSD

PHASE2/PHASE3TerminatedINTERVENTIONAL
Enrollment

121

Participants

Timeline

Start Date

December 13, 2021

Primary Completion Date

March 30, 2023

Study Completion Date

March 30, 2023

Conditions
PTSD
Interventions
DRUG

NYX-783

NYX-783

DRUG

Placebo

Placebo for 50 mg NYX-783

Trial Locations (37)

10036

Aptinyx Clinical Site, New York

19063

Aptinyx Clinical Site, Media

30331

Aptinyx Clinical Site, Atlanta

32256

Aptinyx Clinical Site, Jacksonville

32801

Aptinyx Clinical Site, Orlando

33012

Aptinyx Clinical Site, Hialeah

33014

Aptinyx Clinical Site, Miami Lakes

33020

Aptinyx Clinical Site, Hollywood

33125

Aptinyx Clinical Site, Miami

33174

Aptinyx Clinical Site, Miami

33458

Aptinyx Clinical Site, Jupiter

34972

Aptinyx Clinical Site, Okeechobee

35404

Aptinyx Clinical Site, Tuscaloosa

38119

Aptinyx Clinical Site, Memphis

44720

Aptinyx Clinical Site, North Canton

45219

Aptinyx Clinical Site, Cincinnati

45432

Aptinyx Clinical Site, Dayton

45439

Aptinyx Clinical Site, Kettering

72712

Aptinyx Clinical Site, Bentonville

75093

Aptinyx Clinical Site, Plano

76104

Aptinyx Clinical Site, Fort Worth

77090

Aptinyx Clinical Site, Houston

78737

Aptinyx Clinical Site, Austin

80209

Aptinyx Clinical Site, Denver

80910

Aptinyx Clinical Site, Colorado Springs

85012

Aptinyx Clinical Site, Phoenix

87102

Aptinyx Clinical Site, Albuquerque

89102

Aptinyx Clinical Site, Las Vegas

90502

Aptinyx Clinical Site, Torrance

90706

Aptinyx Clinical Site, Bellflower

91206

Aptinyx Clinical Site, Glendale

92037

Aptinyx Clinical Site, La Jolla

92056

Aptinyx Clinical Site, Oceanside

92506

Aptinyx Clinical Site, Riverside

92591

Aptinyx Clinical Site, Temecula

92705

Aptinyx Clinical Site, Santa Ana

02131

Aptinyx Clinical Site, Boston

Sponsors

Lead Sponsor

Collaborators (1)

All Listed Sponsors
collaborator

Worldwide Clinical Trials

OTHER

lead

Aptinyx

INDUSTRY